Literature DB >> 18433414

Successful deceased donor renal transplant in a sensitized pediatric recipient with the use of plasmapheresis.

Madhura Pradhan1, Ryan M Raffaelli, Curt Lind, Kevin E C Meyers, Bernard S Kaplan, Hobart J Baluarte, Dimitri Monos.   

Abstract

Sensitization following renal transplant is a significant barrier to repeat transplantation in children. We report a successful DD renal transplant, with the use of PP, in an 11-yr-old girl who became highly sensitized following a prior failed transplant. She received PP treatments after failure of high-dose IVIg (Gamimune). We established the effectiveness of PP by attaining a 0% PRA and negative cross-matches after five PP treatments. Subsequently, our patient underwent a second round of scheduled PP. When the PRA was 0%, unacceptable antigens were removed from the UNOS wait list, PP was continued, and a kidney became available within 10 days. The final flow cytometry cross-match with the eventual donor was negative. This success demonstrates that coordination of desensitization by PP and advanced laboratory monitoring techniques with recent policies regarding allocation of organs to pediatric patients provides new opportunities for children awaiting transplantation. Since the transplant, our patient sustained a low-titer increase of anti-HLA antibodies. However, she has had no episodes of acute rejection and has maintained excellent graft function more than 17 months later.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18433414     DOI: 10.1111/j.1399-3046.2008.00938.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  8 in total

Review 1.  Therapeutic plasma exchange for the treatment of pediatric renal diseases in 2013.

Authors:  Caitlin E Carter; Nadine M Benador
Journal:  Pediatr Nephrol       Date:  2013-06-29       Impact factor: 3.714

Review 2.  Pediatric kidney transplantation: a historical review.

Authors:  Priya S Verghese
Journal:  Pediatr Res       Date:  2016-10-12       Impact factor: 3.756

3.  Desensitisation strategies in high-risk children before kidney transplantation.

Authors:  Ankit Sharma; Anne M Durkan
Journal:  Pediatr Nephrol       Date:  2018-01-13       Impact factor: 3.714

4.  Indications, technique, and outcome of therapeutic apheresis in European pediatric nephrology units.

Authors:  Fabio Paglialonga; Claus Peter Schmitt; Rukshana Shroff; Karel Vondrak; Christoph Aufricht; Alan Rees Watson; Gema Ariceta; Michael Fischbach; Gunter Klaus; Tuula Holtta; Sevcan A Bakkaloglu; Alexandra Zurowska; Augustina Jankauskiene; Johan Vande Walle; Betti Schaefer; Elizabeth Wright; Roy Connell; Alberto Edefonti
Journal:  Pediatr Nephrol       Date:  2014-08-20       Impact factor: 3.714

5.  Management of sensitized pediatric patients prior to renal transplantation.

Authors:  Kwanchai Pirojsakul; Dev Desai; Chantale Lacelle; Mouin G Seikaly
Journal:  Pediatr Nephrol       Date:  2016-01-22       Impact factor: 3.714

Review 6.  HLA sensitisation: can it be prevented?

Authors:  Lesley Rees; Jon Jin Kim
Journal:  Pediatr Nephrol       Date:  2014-07-26       Impact factor: 3.714

7.  Desensitization protocol enabling pediatric crossmatch-positive renal transplantation: successful HLA-antibody-incompatible renal transplantation of two highly sensitized children.

Authors:  Anna M Adamusiak; Jelena Stojanovic; Olivia Shaw; Robert Vaughan; Neil J Sebire; Martin Drage; Nicos Kessaris; Stephen D Marks; Nizam Mamode
Journal:  Pediatr Nephrol       Date:  2016-09-01       Impact factor: 3.714

8.  Effects of Fructus Akebiae on learning and memory impairment in a scopolamine-induced animal model of dementia.

Authors:  Jinghua Wang; Xuan Wang; Baosheng Lv; Weixiu Yuan; Zeguo Feng; Weidong Mi; Hong Zhang
Journal:  Exp Ther Med       Date:  2014-06-11       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.